ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is developing eblasakimab, a potential first-in-class antibody targeting the IL-13 receptor in moderate-to-severe atopic dermatitis, and farudodstat, a potent oral inhibitor of the enzyme DHODH, as a potential first-in-class treatment for alopecia areata. ASLAN has teams in San Mateo, California, and in Singapore. For additional information please visit www.aslanpharma.com.
View Top Employees from ASLAN PharmaceuticalsWebsite | http://www.aslanpharma.com |
Ticker | ASLN |
Revenue | $456000 |
Employees | 44 (42 on RocketReach) |
Founded | 2010 |
Address | 83 Clemenceau Ave #12-03 Ue Sq, Singapore, Central Singapore 239920, SG |
Phone | (656) 222-4235 |
Fax | (656) 225-2419 |
Technologies |
JavaScript,
HTML,
PHP
+32 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Medical, Health Care, Pharmaceutical |
Web Rank | 3 Million |
Keywords | Aslan Pharmaceuticals, Aslan, Aslan Pharmaceuticals Limited, Aslanpharma, Aslan003 |
Competitors | Alios BioPharma, Biokine Therapeutics Ltd., Inozyme Pharma, Sage Therapeutics, Visterra Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular ASLAN Pharmaceuticals employee's phone or email?
The ASLAN Pharmaceuticals annual revenue was $456000 in 2024.
Karen Veverka is the Vice President, Head of Medical of ASLAN Pharmaceuticals.
42 people are employed at ASLAN Pharmaceuticals.
ASLAN Pharmaceuticals is based in Singapore, Central Singapore.
The NAICS codes for ASLAN Pharmaceuticals are [3254, 32541, 32, 325].
The SIC codes for ASLAN Pharmaceuticals are [283, 28].